Pivotal role of phospholipase D1 in tumor necrosis factor-α-mediated inflammation and scar formation after myocardial ischemia and reperfusion in mice

American Journal of Pathology

Volumn 184, Issue 9, 2014, Pages 2450-2464

  Schönberger, Tanja ^a   Jürgens, Tobias ^a   Müller, Julia ^b   Armbruster, Nicole ^a   Niermann, Christina ^b   Gorressen, Simone ^b   Sommer, Jan ^b   Tian, Huasong ^c   Di Paolo, Gilbert ^c   Scheller, Jürgen ^b   Fischer, Jens W ^b   Gawaz, Meinrad ^a   Elvers, Margitta ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; I KAPPA B; INTERLEUKIN 1; PHOSPHOLIPASE D1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; PHOSPHOLIPASE D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR INFLAMMATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MACROPHAGE; MOUSE; MYOFIBROBLAST; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SCAR FORMATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR;

ANIMALS; CELL MOVEMENT; CICATRIX; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; MYOCARDIAL REPERFUSION INJURY; PHOSPHOLIPASE D; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906247523     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.06.005     Document Type: Article

References (55)

1. C.J. Murray, and A.D. Lopez Global mortality, disability, and the contribution of risk factors: global Burden of Disease Study Lancet 349 1997 1436 1442
2. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, and M. Galvani et al. Universal definition of myocardial infarction Circulation 116 2007 2634 2653
3. Y. Baumer, C. Leder, M. Ziegler, T. Schonberger, C. Ochmann, A. Perk, H. Degen, B. Schmid-Horch, M. Elvers, G. Munch, M. Ungerer, B. Schlosshauer, and M. Gawaz The recombinant bifunctional protein alphaCD133-GPVI promotes repair of the infarcted myocardium in mice J Thromb Haemost 10 2012 1152 1164
4. M. Ziegler, M. Elvers, Y. Baumer, C. Leder, C. Ochmann, T. Schonberger, T. Jurgens, T. Geisler, B. Schlosshauer, O. Lunov, S. Engelhardt, T. Simmet, and M. Gawaz The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice Circulation 125 2012 685 696
5. E. Ninio Phospholipid mediators in the vessel wall: involvement in atherosclerosis Curr Opin Clin Nutr Metab Care 8 2005 123 131
6. M. McDermott, M.J. Wakelam, and A.J. Morris Phospholipase D Biochem Cell Biol 82 2004 225 253
7. D. English Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signalling Cell Signal 8 1996 341 347
8. A. Honda, M. Nogami, T. Yokozeki, M. Yamazaki, H. Nakamura, H. Watanabe, K. Kawamoto, K. Nakayama, A.J. Morris, M.A. Frohman, and Y. Kanaho Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation Cell 99 1999 521 532
9. A. Nishikimi, H. Fukuhara, W. Su, T. Hongu, S. Takasuga, H. Mihara, Q. Cao, F. Sanematsu, M. Kanai, H. Hasegawa, Y. Tanaka, M. Shibasaki, Y. Kanaho, T. Sasaki, M.A. Frohman, and Y. Fukui Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis Science 324 2009 384 387
10. S.M. Knoepp, M.S. Chahal, Y. Xie, Z. Zhang, D.J. Brauner, M.A. Hallman, S.A. Robinson, S. Han, M. Imai, S. Tomlinson, and K.E. Meier Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells Mol Pharmacol 74 2008 574 584
11. D.J. Powner, T.R. Pettitt, R. Anderson, G.B. Nash, and M.J. Wakelam Stable adhesion and migration of human neutrophils requires phospholipase D-mediated activation of the integrin CD11b/CD18 Mol Immunol 44 2007 3211 3221
12. M. Elvers, D. Stegner, I. Hagedorn, C. Kleinschnitz, A. Braun, M.E. Kuijpers, M. Boesl, Q. Chen, J.W. Heemskerk, G. Stoll, M.A. Frohman, and B. Nieswandt Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1 Sci Signal 3 2010 ra1
13. V. Natarajan, W.M. Scribner, C.M. Hart, and S. Parthasarathy Oxidized low density l ipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis J Lipid Res 36 1995 2005 2016
14. W. Siess, and G. Tigyi Thrombogenic and atherogenic activities of lysophosphatidic acid J Cell Biochem 92 2004 1086 1094
15. Y.J. Xu, O.A. Aziz, P. Bhugra, A.S. Arneja, M.R. Mendis, and N.S. Dhalla Potential role of lysophosphatidic acid in hypertension and atherosclerosis Can J Cardiol 19 2003 1525 1536
16. J. Gomez-Cambronero New concepts in phospholipase D signaling in inflammation and cancer ScientificWorldJournal 10 2010 1356 1369
17. P.D. Issuree, P.N. Pushparaj, S. Pervaiz, and A.J. Melendez Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities FASEB J 23 2009 2412 2424
18. S. Sethu, P.N. Pushparaj, and A.J. Melendez Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis PLoS One 5 2010 e10506
19. C. Dall'Armi, A. Hurtado-Lorenzo, H. Tian, E. Morel, A. Nezu, R.B. Chan, W.H. Yu, K.S. Robinson, O. Yeku, S.A. Small, K. Duff, M.A. Frohman, M.R. Wenk, A. Yamamoto, and G. Di Paolo The phospholipase D1 pathway modulates macroautophagy Nat Commun 1 2010 142
20. T. Schonberger, M. Ziegler, O. Borst, I. Konrad, B. Nieswandt, S. Massberg, C. Ochmann, T. Jurgens, P. Seizer, H. Langer, G. Munch, M. Ungerer, K.T. Preissner, M. Elvers, and M. Gawaz The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice Am J Physiol Cell Physiol 303 2012 C757 C766
21. O. Borst, C. Ochmann, T. Schonberger, C. Jacoby, K. Stellos, P. Seizer, U. Flogel, F. Lang, and M. Gawaz Methods employed for induction and analysis of experimental myocardial infarction in mice Cell Physiol Biochem 28 2011 1 12
22. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M.A. Basson, J.D. Licht, J.T. Pena, S.H. Rouhanifard, M.U. Muckenthaler, T. Tuschl, G.R. Martin, J. Bauersachs, and S. Engelhardt MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
23. M. Elvers, M. Grenegard, H. Khoshjabinzadeh, P. Munzer, O. Borst, H. Tian, G. Di Paolo, F. Lang, M. Gawaz, T.L. Lindahl, and K. Falker A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity Cell Signal 24 2012 1743 1752
24. T. Freudenberger, M. Oppermann, H.K. Heim, P. Mayer, G. Kojda, K. Schror, and J.W. Fischer Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice Basic Res Cardiol 105 2010 479 486
25. A. Melchior-Becker, G. Dai, Z. Ding, L. Schafer, J. Schrader, M.F. Young, and J.W. Fischer Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype J Biol Chem 286 2011 17365 17375
26. N. Lehman, M. Di Fulvio, N. McCray, I. Campos, F. Tabatabaian, and J. Gomez-Cambronero Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2 Blood 108 2006 3564 3572
27. N. Parameswaran, and S. Patial Tumor necrosis factor-alpha signaling in macrophages Crit Rev Eukaryot Gene Expr 20 2010 87 103
28. P.C. Taylor, and M. Feldmann Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis Nat Rev Rheumatol 5 2009 578 582
29. P. Kleinbongard, R. Schulz, and G. Heusch TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Fail Rev 16 2011 49 69
30. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu Rev Immunol 18 2000 621 663
31. A.R. Brasier The NF-kappaB regulatory network Cardiovasc Toxicol 6 2006 111 130
32. S.S. Iyer, R.S. Agrawal, C.R. Thompson, S. Thompson, J.A. Barton, and D.J. Kusner Phospholipase D1 regulates phagocyte adhesion J Immunol 176 2006 3686 3696
33. I.I. Moraru, L.M. Popescu, N. Maulik, X. Liu, and D.K. Das Phospholipase D signaling in ischemic heart Biochim Biophys Acta 1139 1992 148 154
34. M.V. Cohen, Y. Liu, G.S. Liu, P. Wang, C. Weinbrenner, G.A. Cordis, D.K. Das, and J.M. Downey Phospholipase D plays a role in ischemic preconditioning in rabbit heart Circulation 94 1996 1713 1718
35. M.R. Dent, T. Singal, N.S. Dhalla, and P.S. Tappia Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction J Cell Mol Med 8 2004 526 536
36. M.Y. Lee, S.Y. Kim, D.S. Min, Y.S. Choi, S.L. Shin, M.H. Chun, S.B. Lee, M.S. Kim, and Y.H. Jo Upregulation of phospholipase D in astrocytes in response to transient forebrain ischemia Glia 30 2000 311 317
37. D.W. Kang, J.Y. Lee, D.H. Oh, S.Y. Park, T.M. Woo, M.K. Kim, M.H. Park, Y.H. Jang, and S. Min do Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells Exp Mol Med 41 2009 678 685
38. M.H. Park, and S. Min do Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells Biochem Biophys Res Commun 412 2011 710 715
39. W.H. Ali, Q. Chen, K.E. Delgiorno, W. Su, J.C. Hall, T. Hongu, H. Tian, Y. Kanaho, G. Di Paolo, H.C. Crawford, and M.A. Frohman Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment PLoS One 8 2013 e55325
40. M. Locati, E. Riboldi, R. Bonecchi, P. Transidico, S. Bernasconi, B. Haribabu, A.J. Morris, A. Mantovani, and S. Sozzani Selective induction of phospholipase D1 in pathogen-activated human monocytes Biochem J 358 2001 119 125
41. D.W. Kang, G. Min, Y. Park do, K.W. Hong, and S. Min do Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells Exp Mol Med 42 2010 555 564
42. R. Schulz, and G. Heusch Tumor necrosis factor-alpha and its receptors 1 and 2: yin and yang in myocardial infarction? Circulation 119 2009 1355 1357
43. F. Mollinedo, C. Gajate, and I. Flores Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells J Immun 153 1994 2457 2469
44. C. Grothusen, A. Hagemann, T. Attmann, J. Braesen, O. Broch, J. Cremer, and J. Schoettler Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury ScientificWorldJournal 2012 2012 737585
45. A. Abbate, B.W. Van Tassell, and G.G. Biondi-Zoccai Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events BioDrugs 26 2012 217 233
46. S. Toldo, A.M. Schatz, E. Mezzaroma, R. Chawla, T.W. Stallard, W.C. Stallard, A. Jahangiri, B.W. Van Tassell, and A. Abbate Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse Cardiovasc Drugs Ther 26 2012 273 276
47. T. Anzai Post-infarction inflammation and left ventricular remodeling: a double-edged sword Circ J 77 2013 580 587
48. B. Jiang, and R. Liao The paradoxical role of inflammation in cardiac repair and regeneration J Cardiovasc Transl Res 3 2010 410 416
49. M. Sun, F. Dawood, W.H. Wen, M. Chen, I. Dixon, L.A. Kirshenbaum, and P.P. Liu Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction Circulation 110 2004 3221 3228
50. R. Van Kerckhoven, E.A. Kalkman, P.R. Saxena, and R.G. Schoemaker Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts Cardiovasc Res 46 2000 316 323
51. D.A. Foster, and L. Xu Phospholipase D in cell proliferation and cancer Mol Cancer Res 1 2003 789 800
52. J. Gomez-Cambronero Phosphatidic acid, phospholipase D and tumorigenesis Adv Biol Regul 54 2014 197 206
53. T. Joseph, R. Wooden, A. Bryant, M. Zhong, Z. Lu, and D.A. Foster Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2 Biochem Biophys Res Commun 289 2001 1019 1024
54. Z. Lu, A. Hornia, T. Joseph, T. Sukezane, P. Frankel, M. Zhong, S. Bychenok, L. Xu, L.A. Feig, and D.A. Foster Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts Mol Cell Biol 20 2000 462 467
55. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47